EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review

Paola Manzo iD, Valentina Giudice iD, Filomena Napolitano iD, Danilo De Novellis iD, Bianca Serio, Paolo Moscato, Nunzia Montuori iD, Carmine Selleri iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310519 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paola Manzo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", 84131 Salerno, Italy. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microenvironment plays an essential role in multiple myeloma (MM) development, progression, cell proliferation, survival, immunological escape, and drug resistance. Mesenchymal stromal cells and macrophages release tolerogenic cytokines and favor anti-apoptotic signaling pathway activation, while the urokinase plasminogen activator receptor (uPAR) system contributes to migration through an extracellular matrix. Here, we first summarized the role of macrophages and the uPAR system in MM pathogenesis, and then we reported the potential therapeutic effects of uPAR inhibitors in a case series of primary MM-derived adherent cells. Our preliminary results showed that after uPAR inhibitor treatments, interleukein-6 (mean ± SD, 8734.95 ± 4169.2 pg/mL vs. 359.26 ± 393.8 pg/mL, pre- vs. post-treatment; p = 0.0012) and DKK-1 levels (mean ± SD, 7005.41 ± 6393.4 pg/mL vs. 61.74 ± 55.2 pg/mL, pre- vs. post-treatment; p = 0.0043) in culture medium were almost completely abolished, supporting further investigation of uPAR blockade as a therapeutic strategy for MM treatment. Therefore, uPAR inhibitors could exert both anti-inflammatory and pro-immunosurveillance activity. However, our preliminary results need further validation in additional in vitro and in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Urokinase Plasminogen ActivatorMultiple MyelomaHumansUrokinase-Type Plasminogen ActivatorSignal TransductionMacrophagesTumor Microenvironment

Stichwörter der Autor:innen

macrophagesmultiple myelomaurokinase plasminogen activator receptor

Substanzen

Receptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Autor:innen und Institutionen

  • Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", 84131 Salerno, Italy.
  • Department of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy.
  • Department of Translational Medical Sciences, University of Naples "Federico II", 80138 Naples, Italy.
  • Rheumatology Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", 84131 Salerno, Italy.

ORCID-Profile: Paola Manzo, Valentina Giudice, Filomena Napolitano, Danilo De Novellis, Nunzia Montuori, Carmine Selleri

Zitieren

APA

Manzo, P., Giudice, V., Napolitano, F., De Novellis, D., Serio, B., Moscato, P., Montuori, N., & Selleri, C. (2023). Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310519

Vancouver

Manzo P, Giudice V, Napolitano F, De Novellis D, Serio B, Moscato P, et al. Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310519

BibTeX
@article{Manzo2023,
  author = {Manzo, Paola and Giudice, Valentina and Napolitano, Filomena and De Novellis, Danilo and Serio, Bianca and Moscato, Paolo and Montuori, Nunzia and Selleri, Carmine},
  title = {Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310519}
}
Kostenlos starten →